CONTINUING EDUCATION AT EMBRAACE Overall Learning Objectives Upon completion of each of these activities, learners will be able to: Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes and metabolism Apply newfound knowledge to the diagnosis and management of patients with disorders of endocrinology, diabetes or metabolism for improved patient outcomes Assess the potential applications of emerging scientific advances that affect the practice of endocrinology. Maintenance of Certification Successful completion of this CME activity enables the participant to earn up to 23 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points. Accreditation and Designation Statements The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Association of Clinical Endocrinologists (AACE) designates this live activity for 25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Main Conference: 25 AMA PRA Category 1 CreditsTM Afternoon Pre-Congress Sessions: 4 AMA PRA Category 1 CreditsTM AACE/ ACE Endocrine Neck Ultrasound 2020: Hands-On Approach :10 AMA PRA Category 1 CreditsTM Disclaimer The information provided at this activity is for continuing education purposes only and is not meant to substitute the independent medical judgment of a health care provider relative to diagnostic and treatment options of a specific patient’s medical condition. Disclosure and Resolution of Conflict of Interest The American Association of Clinical Endocrinologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Association of Clinical Endocrinologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Association of Clinical Endocrinologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Association of Clinical Endocrinologists' educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Association of Clinical Endocrinologists' activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. The following members of the planning committee have disclosed these relationships: Committee Member Company Relationship Dace Trence Sanofi Medtronic Stock Jonathan Leffert Novo Nordisk Sanofi US AbbVie MYLAN KOWA Research Institute Research Grant Research Grant Research Grant Research Grant Guillermo Umpierrez Sanofi Novo Nordisk Dexcom Stock Irina Bancos HRA Pharma Advisory Board Susan Samson Corcept Pharmaceuticals Advisory Board Robert Wermers Alexion Research Funding All other planning committee members and staff have disclosed no relevant financial relationships with commercial interests. Please see individual session descriptions for faculty disclosures.